alscenter.orgWhat is ALS The Robert Packard Center for ALS Research

Skip Navigation Menu Home Make a Gift Answer ALS Fiesta 5K Make a Gift Contact Enter Search Phrase What is ALS Causes Symptoms and Diagnosis Treatment Living with ALS Get Involved Connect With Our Community Participate in Events Research Project List Completed Projects Our Approach Resources for Scientists About Us Our Story Our Organization Funding News & Media ALS Alert Newsletter News Media New Phase 2 trial results show promise for ALS Results of a new Phase 2 randomized clinical trial in 137 patients with ALS showed that treatment could significantly slow functional decline over 24 weeks compared to placebo. Learn more Packard Center announces new Scientific Executive Committee The Packard Center is delighted to announce the appointment of Aaron Gitler, Ph.D., Piera Pasinelli, Ph.D., Sami Barmada, M.D., Ph.D. and Christopher Donnelly, Ph.D. Learn more Packard awards grant to fund study of microglia in ALS/FTD This grant was made possible by a generous donation from The Bruce Edwards Foundation. Read more Research Bit: ALS-linked mutation leads to nuclear defects New project by Packard Center scientist Alyssa Coyne provides new detail on the underlying and initiating events through which the C9orf72mutation causes disease. Learn more What is ALS? Amyotrophic lateral sclerosis (ALS), also known as called Lou Gehrig's, disease is a rapidly progressive, fatal neurological disease that attacks the nerve cells (neurons) responsible for controlling voluntary muscles. The average life span from diagnosis is two to five years. There is no cure. Understanding ALS Our mission is to fund and support ALS research around the world Our goal is to find a cure Meet the Packard Center Team Packard Center Donors One family's commitment to ALS research inspires hope. ALS Patients Two men, fighting ALS with passion and determination. Packard Research Projects 150 Scientists 27 Projects 18 Institutions 5 Countries Working together to find a cure. Explore our Research Latest News & Articles View All September 14, 2020 Key link uncovered between C9orf72 mutation and TDP-43 pathology in ALS/FTD September 3, 2020 New Phase 2 trial results show promise for ALS August 14, 2020 Research Bit: Nuclear pore complex quality control in C9orf72 ALS/FTD August 14, 2020 Research Bit: Enhanced insulin signaling ameliorates C9orf72 repeat toxicity in Drosophila Join the Family - Get Involved with the Packard Center Connect with Our Community Support Our Events Donate Subscribe to our Newsletter You can make a difference. Tell us your story. Get involved. Make a Gift. The hope is in the science. The John G. Rangos Building 855 N. Wolfe Street Suite 270, Room 232 Baltimore, MD 21205 Contact the Packard Center © , The Robert Packard Center for ALS Research at Johns Hopkins. All rights reserved. Explore Packard What is ALS? Get Involved Research About Us News & Media Donate Photography Credits Packard Sites & Partners Fiesta 5K Brain Science Insitute Answer ALS Follow Packard Facebook Twitter Instagram YouTube Subscribe to our Newsletter Sign up for e-mail updates by submitting your email address here. Spam Control Text: Please leave this field empty...